Cite

HARVARD Citation

    Sakai, H. et al. (n.d.). 521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC). European journal of cancer. pp. S110-S111. [Online]. 
  
Back to record